RECRUITING

Hydrus Microstent as a Quality of Life Consideration

Description

The study aims to identify if Hydrus microstent implantation in patients with open angle glaucoma (OAG) at the time of cataract surgery improves quality of life for patients and explore what quality of life factors motivate patients.

Conditions

Open Angle Glaucoma
Talk to us

Related Conditions:

Open Angle Glaucoma

Study Overview

On this page

Study Details

Study overview

The study aims to identify if Hydrus microstent implantation in patients with open angle glaucoma (OAG) at the time of cataract surgery improves quality of life for patients and explore what quality of life factors motivate patients.

Hydrus Microstent as a Quality of Life Consideration

Hydrus Microstent as a Quality of Life Consideration

Condition
Open Angle Glaucoma
Intervention / Treatment

-

Contacts and Locations

Fresno

Terri Smith, Fresno, California, United States, 93720

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Clinical diagnosis of mild to moderate open angle glaucoma as defined by with visually significant age-related cataract undergoing uncomplicated cataract surgery and Hydrus Microstent
  • * Current treatment with one or more ocular hypotensive medication
  • * Corneal thickness between 470 to 610µm
  • * Potential of good best corrected visual acuity at distance in the investigator's judgement of at least 0.1 LogMAR (20/25) postoperatively
  • * Clinical diagnosis of secondary glaucoma (traumatic, neovascular, mixed-mechanism, uveitic glaucoma)
  • * corneal opacity or angle abnormalities that make visualizing the angle difficult
  • * Past ocular surgery
  • * History of ocular, systemic medications, or systemic diseases/co-morbidities that significantly impact on quality of life or vision (e.g. advanced macular degeneration, autoimmune diseases, mental illness/depression, uncontrolled systemic disease on polypharmacy)
  • * Severe dry eye requiring secretagogues, serum eyedrops, topical corticosteroids, amniotic membrane grafts

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

InSight Vision Center Medical Group, Inc,

Study Record Dates

2024-04-01